Cyber Surgery is a late development stage medical device company developing a new technology for ultra-high precision robotic assistance for spine and other applications.
Robotic-assisted surgery for the spine, our initial application, is expected to grow at 34% CAGR, making for an estimated $4 billion market by 2030. Cyber Surgery has developed a novel mechanical tracking technology, a different approach from the rest of the competitors. This disruptive technology increases accuracy and improves patient safety, and it will allow us to use our robot for other spine procedures and expand to new robotic surgery fields not addressed now. In addition, our system uses artificial intelligence to guide the surgeon, optimize the user interface and provide business intelligence for hospitals. The technology has been thoroughly validated in anatomical models and human cadaver and is ready for first-in-human trials in the coming months.
Cyber Surgery has raised $7 million to date between grants, government loans and equity funding. We are currently raising funds to complete clinical validation, obtain FDA and EU regulatory approval and validate the robot in 25 hospitals.